HomeKALV • NASDAQ
Follow
Kalvista Pharmaceuticals Inc
Previous close
$11.11
Day range
$10.97 - $11.41
Year range
$6.60 - $16.88
Market cap
467.02M USD
Avg Volume
998.71K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jan 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 10.63M | 54.43% |
Net income | -29.03M | -36.26% |
Net profit margin | — | — |
Earnings per share | -0.84 | -12.00% |
EBITDA | -32.94M | -23.17% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jan 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 75.59M | -55.97% |
Total assets | 113.97M | -43.99% |
Total liabilities | 25.38M | 33.42% |
Total equity | 88.58M | — |
Shares outstanding | 42.19M | — |
Price to book | 4.34 | — |
Return on assets | -65.59% | — |
Return on capital | -75.98% | — |
Cash Flow
Net change in cash
(USD) | Jan 2024info | Y/Y change |
---|---|---|
Net income | -29.03M | -36.26% |
Cash from operations | -27.57M | -196.81% |
Cash from investing | -6.70M | -166.27% |
Cash from financing | 284.00K | -99.51% |
Net change in cash | -34.61M | -174.49% |
Free cash flow | -22.37M | -182.89% |
About
Founded
2004
Website
Employees
118